

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of interleukin-12 production (GO:0032695) | 4.79593926 |
| 2 | response to peptidoglycan (GO:0032494) | 4.56382779 |
| 3 | response to pheromone (GO:0019236) | 4.54754269 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 4.20368288 |
| 5 | amino sugar catabolic process (GO:0046348) | 4.08514862 |
| 6 | macrophage activation involved in immune response (GO:0002281) | 3.91163281 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 3.73422821 |
| 8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.67874017 |
| 9 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.59734340 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.53430626 |
| 11 | negative regulation of cell killing (GO:0031342) | 3.53430626 |
| 12 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.52036764 |
| 13 | regulation of mast cell degranulation (GO:0043304) | 3.44868300 |
| 14 | granulocyte activation (GO:0036230) | 3.44692950 |
| 15 | G-protein coupled receptor internalization (GO:0002031) | 3.42343743 |
| 16 | N-acetylneuraminate metabolic process (GO:0006054) | 3.38340236 |
| 17 | glycosphingolipid catabolic process (GO:0046479) | 3.35584126 |
| 18 | synaptic vesicle endocytosis (GO:0048488) | 3.30605123 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.28430684 |
| 20 | phagosome maturation (GO:0090382) | 3.24577260 |
| 21 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.24054878 |
| 22 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.20106126 |
| 23 | positive regulation of mast cell degranulation (GO:0043306) | 3.20106126 |
| 24 | positive regulation of antigen processing and presentation (GO:0002579) | 3.19413929 |
| 25 | histone H3-K4 trimethylation (GO:0080182) | 3.18774146 |
| 26 | positive regulation of mast cell activation (GO:0033005) | 3.18395808 |
| 27 | neutrophil activation (GO:0042119) | 3.17710864 |
| 28 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.15450037 |
| 29 | regulation of mononuclear cell migration (GO:0071675) | 3.15278158 |
| 30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.15198670 |
| 31 | regulation of mast cell activation (GO:0033003) | 3.11019255 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.09997427 |
| 33 | macrophage activation (GO:0042116) | 3.06902774 |
| 34 | cellular extravasation (GO:0045123) | 3.06321875 |
| 35 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.05338606 |
| 36 | NIK/NF-kappaB signaling (GO:0038061) | 3.04993769 |
| 37 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.03724645 |
| 38 | oligosaccharide catabolic process (GO:0009313) | 2.98811335 |
| 39 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.97749023 |
| 40 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.97031841 |
| 41 | regulation of leukocyte degranulation (GO:0043300) | 2.95680723 |
| 42 | glycolipid catabolic process (GO:0019377) | 2.95283022 |
| 43 | ceramide catabolic process (GO:0046514) | 2.91936738 |
| 44 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.91665389 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 2.90851471 |
| 46 | detection of other organism (GO:0098543) | 2.86869780 |
| 47 | regulation of antigen processing and presentation (GO:0002577) | 2.86361341 |
| 48 | negative regulation of interleukin-6 production (GO:0032715) | 2.85773134 |
| 49 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.85543378 |
| 50 | germinal center formation (GO:0002467) | 2.84736110 |
| 51 | regulation of ARF protein signal transduction (GO:0032012) | 2.84606269 |
| 52 | macroautophagy (GO:0016236) | 2.83389622 |
| 53 | negative regulation of interleukin-1 production (GO:0032692) | 2.82798852 |
| 54 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.82477147 |
| 55 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.80832984 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.80552777 |
| 57 | histone H3-K4 methylation (GO:0051568) | 2.80342050 |
| 58 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.79891355 |
| 59 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77937273 |
| 60 | adhesion of symbiont to host cell (GO:0044650) | 2.77529775 |
| 61 | virion attachment to host cell (GO:0019062) | 2.77529775 |
| 62 | glutamate secretion (GO:0014047) | 2.75044245 |
| 63 | lysosome organization (GO:0007040) | 2.74630212 |
| 64 | lytic vacuole organization (GO:0080171) | 2.74630212 |
| 65 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.73007874 |
| 66 | regulation of chemokine biosynthetic process (GO:0045073) | 2.72689797 |
| 67 | positive regulation of leukocyte degranulation (GO:0043302) | 2.72459258 |
| 68 | modulation by symbiont of host defense response (GO:0052031) | 2.71311528 |
| 69 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.71311528 |
| 70 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71311528 |
| 71 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71311528 |
| 72 | modulation by symbiont of host immune response (GO:0052553) | 2.71311528 |
| 73 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71311528 |
| 74 | vocalization behavior (GO:0071625) | 2.70452436 |
| 75 | detection of bacterium (GO:0016045) | 2.69107746 |
| 76 | detection of external biotic stimulus (GO:0098581) | 2.68255031 |
| 77 | microglial cell activation (GO:0001774) | 2.67749223 |
| 78 | T-helper 1 type immune response (GO:0042088) | 2.67458966 |
| 79 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.67386725 |
| 80 | defense response to protozoan (GO:0042832) | 2.66314722 |
| 81 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.66111558 |
| 82 | locomotory exploration behavior (GO:0035641) | 2.65523166 |
| 83 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.64093979 |
| 84 | righting reflex (GO:0060013) | 2.64043717 |
| 85 | synaptic vesicle maturation (GO:0016188) | 2.63374648 |
| 86 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.63302078 |
| 87 | glutamate receptor signaling pathway (GO:0007215) | 2.62872032 |
| 88 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.61412430 |
| 89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61282889 |
| 90 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.60569168 |
| 91 | negative regulation of hormone metabolic process (GO:0032351) | 2.60569168 |
| 92 | response to protozoan (GO:0001562) | 2.59451269 |
| 93 | mannose metabolic process (GO:0006013) | 2.58034451 |
| 94 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.57794301 |
| 95 | sphingolipid catabolic process (GO:0030149) | 2.56322919 |
| 96 | cellular response to type I interferon (GO:0071357) | 2.54947565 |
| 97 | type I interferon signaling pathway (GO:0060337) | 2.54947565 |
| 98 | B cell mediated immunity (GO:0019724) | 2.54191862 |
| 99 | regulation of regulated secretory pathway (GO:1903305) | 2.54069395 |
| 100 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.53541152 |
| 101 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.53346059 |
| 102 | negative regulation of innate immune response (GO:0045824) | 2.53283935 |
| 103 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.53214602 |
| 104 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.53214602 |
| 105 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.53214602 |
| 106 | regulation of synapse maturation (GO:0090128) | 2.53187287 |
| 107 | glycine transport (GO:0015816) | 2.53133063 |
| 108 | response to type I interferon (GO:0034340) | 2.52629949 |
| 109 | fibroblast migration (GO:0010761) | 2.52560696 |
| 110 | cellular potassium ion homeostasis (GO:0030007) | 2.52412800 |
| 111 | membrane lipid catabolic process (GO:0046466) | 2.51851780 |
| 112 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.47965589 |
| 113 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.47038124 |
| 114 | positive regulation of interleukin-17 production (GO:0032740) | 2.46385680 |
| 115 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.46111354 |
| 116 | positive regulation of heat generation (GO:0031652) | 2.45649616 |
| 117 | L-amino acid import (GO:0043092) | 2.44625792 |
| 118 | regulation of interleukin-6 production (GO:0032675) | 2.43331592 |
| 119 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.43265850 |
| 120 | membrane depolarization during action potential (GO:0086010) | 2.42954435 |
| 121 | respiratory burst (GO:0045730) | 2.42720631 |
| 122 | detection of biotic stimulus (GO:0009595) | 2.41979547 |
| 123 | synaptic transmission, glutamatergic (GO:0035249) | 2.41864771 |
| 124 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.41584049 |
| 125 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.41536578 |
| 126 | lymphocyte chemotaxis (GO:0048247) | 2.41481686 |
| 127 | female gonad development (GO:0008585) | 2.41008695 |
| 128 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.40594849 |
| 129 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.40419554 |
| 130 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.40349260 |
| 131 | cellular anion homeostasis (GO:0030002) | 2.38927841 |
| 132 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.38716885 |
| 133 | peptidyl-lysine trimethylation (GO:0018023) | 2.38506559 |
| 134 | neutrophil mediated immunity (GO:0002446) | 2.38350506 |
| 135 | myeloid leukocyte activation (GO:0002274) | 2.38237064 |
| 136 | regulation of tumor necrosis factor production (GO:0032680) | 2.38181126 |
| 137 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.38065410 |
| 138 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.37547649 |
| 139 | response to muramyl dipeptide (GO:0032495) | 2.37363211 |
| 140 | synaptic vesicle exocytosis (GO:0016079) | 2.32205870 |
| 141 | alanine transport (GO:0032328) | 2.31758772 |
| 142 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.30799529 |
| 143 | histone lysine demethylation (GO:0070076) | 2.30673768 |
| 144 | proline transport (GO:0015824) | 2.28398574 |
| 145 | modulation by virus of host process (GO:0019054) | 2.26710921 |
| 146 | dendrite morphogenesis (GO:0048813) | 2.24838489 |
| 147 | negative regulation of granulocyte differentiation (GO:0030853) | 2.24252271 |
| 148 | detection of molecule of bacterial origin (GO:0032490) | 2.24119600 |
| 149 | response to auditory stimulus (GO:0010996) | 2.21596362 |
| 150 | response to host immune response (GO:0052572) | 2.20552663 |
| 151 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.20552663 |
| 152 | prostate gland growth (GO:0060736) | 2.19128927 |
| 153 | histone lysine methylation (GO:0034968) | 2.18637449 |
| 154 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.18323677 |
| 155 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.18177382 |
| 156 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.17645967 |
| 157 | Golgi to endosome transport (GO:0006895) | 2.17451206 |
| 158 | protein localization to synapse (GO:0035418) | 2.16613326 |
| 159 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.16142590 |
| 160 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.16032627 |
| 161 | adult walking behavior (GO:0007628) | 2.15946114 |
| 162 | glycerophospholipid catabolic process (GO:0046475) | 2.15933774 |
| 163 | histone H3-K36 demethylation (GO:0070544) | 2.15519544 |
| 164 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.15227441 |
| 165 | positive regulation of fibroblast migration (GO:0010763) | 2.14535324 |
| 166 | membrane hyperpolarization (GO:0060081) | 2.13789958 |
| 167 | histone demethylation (GO:0016577) | 2.12587066 |
| 168 | cAMP-mediated signaling (GO:0019933) | 2.10687668 |
| 169 | positive regulation of protein dephosphorylation (GO:0035307) | 2.09818252 |
| 170 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.09324501 |
| 171 | positive regulation of synapse maturation (GO:0090129) | 2.08776679 |
| 172 | regulation of postsynaptic membrane potential (GO:0060078) | 2.08435296 |
| 173 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.08225809 |
| 174 | long-term memory (GO:0007616) | 2.07966287 |
| 175 | stress granule assembly (GO:0034063) | 2.07341785 |
| 176 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.06969459 |
| 177 | sphingosine metabolic process (GO:0006670) | 2.06315147 |
| 178 | regulation of synaptic vesicle transport (GO:1902803) | 2.06223498 |
| 179 | gamma-aminobutyric acid transport (GO:0015812) | 2.05097999 |
| 180 | modulation by symbiont of host cellular process (GO:0044068) | 2.04845843 |
| 181 | neuron-neuron synaptic transmission (GO:0007270) | 2.04481163 |
| 182 | cell differentiation in hindbrain (GO:0021533) | 2.04427390 |
| 183 | membrane depolarization (GO:0051899) | 2.03831897 |
| 184 | striatum development (GO:0021756) | 2.02322076 |
| 185 | protein demethylation (GO:0006482) | 2.02192954 |
| 186 | protein dealkylation (GO:0008214) | 2.02192954 |
| 187 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.01537244 |
| 188 | regulation of synapse structural plasticity (GO:0051823) | 2.01396195 |
| 189 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 1.99557690 |
| 190 | response to host (GO:0075136) | 1.99557690 |
| 191 | response to host defenses (GO:0052200) | 1.99557690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.94950918 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.28395991 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.88213452 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.40786318 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.22023766 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.99390499 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.87893287 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74116355 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.66410221 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.65922440 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.56988644 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.54649873 |
| 13 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29379410 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28894961 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.26882174 |
| 16 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.21820538 |
| 17 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18019348 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.16898142 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.13328416 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.11386117 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.09254148 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.07749782 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05319445 |
| 24 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.94179332 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.89171270 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87575844 |
| 27 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.87486821 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86104558 |
| 29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.81293725 |
| 30 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.76446144 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76299937 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.76134827 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.76134827 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.75723986 |
| 35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.75213295 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74976282 |
| 37 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.74176612 |
| 38 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.73201310 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.72777737 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.71258856 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71251910 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69773438 |
| 43 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.69668308 |
| 44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66926578 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65458796 |
| 46 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64601284 |
| 47 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.64486857 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63750218 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61512195 |
| 50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.61321913 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60041851 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59993757 |
| 53 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.59712294 |
| 54 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.59386733 |
| 55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.58793709 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56240265 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55699612 |
| 58 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.54505893 |
| 59 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.54413445 |
| 60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53285885 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53043888 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.52883348 |
| 63 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.52378152 |
| 64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49571198 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47037244 |
| 66 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.46954577 |
| 67 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45132158 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.45002713 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43641673 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43276097 |
| 71 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.42772410 |
| 72 | * P68_20966046_ChIP-Seq_HELA_Human | 1.42020217 |
| 73 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.41329138 |
| 74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40364598 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38926358 |
| 76 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.38876710 |
| 77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38538441 |
| 78 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.38508880 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37830061 |
| 80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37710527 |
| 81 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.37105393 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37086635 |
| 83 | MAF_26560356_Chip-Seq_TH2_Human | 1.37057162 |
| 84 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36657645 |
| 85 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.36582961 |
| 86 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.36187740 |
| 87 | MAF_26560356_Chip-Seq_TH1_Human | 1.35059274 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35013269 |
| 89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.33531091 |
| 90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33209543 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33153312 |
| 92 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.33153312 |
| 93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33135774 |
| 94 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.32638120 |
| 95 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32064940 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31208114 |
| 97 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30913943 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30592165 |
| 99 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.30209362 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29670644 |
| 101 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.28753804 |
| 102 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.25632803 |
| 103 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.24872077 |
| 104 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23980210 |
| 105 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.23530941 |
| 106 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.23221080 |
| 107 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22920078 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.22155158 |
| 109 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.21874032 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20755378 |
| 111 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20739291 |
| 112 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.20614915 |
| 113 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20251458 |
| 114 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.20172929 |
| 115 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19750445 |
| 116 | * AR_19668381_ChIP-Seq_PC3_Human | 1.19572120 |
| 117 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17894576 |
| 118 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17845303 |
| 119 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17058047 |
| 120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16710353 |
| 121 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.16407430 |
| 122 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16350868 |
| 123 | SA1_27219007_Chip-Seq_Bcells_Human | 1.15555449 |
| 124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15532662 |
| 125 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15359232 |
| 126 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14874853 |
| 127 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14843867 |
| 128 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14694807 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.13930151 |
| 130 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13495424 |
| 131 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11588431 |
| 132 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11504729 |
| 133 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.10806455 |
| 134 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10398630 |
| 135 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10361441 |
| 136 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10012227 |
| 137 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09982937 |
| 138 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.09018041 |
| 139 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08847192 |
| 140 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.08819660 |
| 141 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08734394 |
| 142 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08205823 |
| 143 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07718434 |
| 144 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07526961 |
| 145 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07200517 |
| 146 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.06837886 |
| 147 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.06691495 |
| 148 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06438573 |
| 149 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.06416261 |
| 150 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05546858 |
| 151 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05281442 |
| 152 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05264644 |
| 153 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05251266 |
| 154 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05210555 |
| 155 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05184852 |
| 156 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04628698 |
| 157 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04132414 |
| 158 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03961627 |
| 159 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03934160 |
| 160 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03790072 |
| 161 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02333908 |
| 162 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02293282 |
| 163 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01402325 |
| 164 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00881715 |
| 165 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00484847 |
| 166 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.99137213 |
| 167 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99006069 |
| 168 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98574158 |
| 169 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98539097 |
| 170 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98468787 |
| 171 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98310742 |
| 172 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98005963 |
| 173 | MYB_26560356_Chip-Seq_TH2_Human | 0.97462193 |
| 174 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96697850 |
| 175 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96624648 |
| 176 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96608925 |
| 177 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96498064 |
| 178 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96482855 |
| 179 | P300_27268052_Chip-Seq_Bcells_Human | 0.96374638 |
| 180 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95861145 |
| 181 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95731736 |
| 182 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95018714 |
| 183 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.94148168 |
| 184 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93698682 |
| 185 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93046452 |
| 186 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92454749 |
| 187 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92317934 |
| 188 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91928090 |
| 189 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.91511715 |
| 190 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91311533 |
| 191 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90948431 |
| 192 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90797797 |
| 193 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.90764962 |
| 194 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.90745826 |
| 195 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90000721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.42801808 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.42609103 |
| 3 | MP0003303_peritoneal_inflammation | 3.87212485 |
| 4 | MP0006082_CNS_inflammation | 3.46020833 |
| 5 | MP0009840_abnormal_foam_cell | 3.33089188 |
| 6 | MP0003724_increased_susceptibility_to | 3.26927884 |
| 7 | MP0003436_decreased_susceptibility_to | 3.19511885 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.93992036 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.91529990 |
| 10 | MP0003787_abnormal_imprinting | 2.79442928 |
| 11 | MP0002419_abnormal_innate_immunity | 2.73181581 |
| 12 | MP0005646_abnormal_pituitary_gland | 2.68135119 |
| 13 | MP0009785_altered_susceptibility_to | 2.65764780 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.56636740 |
| 15 | MP0008961_abnormal_basal_metabolism | 2.53315202 |
| 16 | MP0001486_abnormal_startle_reflex | 2.45567481 |
| 17 | MP0003283_abnormal_digestive_organ | 2.43382630 |
| 18 | MP0002102_abnormal_ear_morphology | 2.43303245 |
| 19 | MP0005025_abnormal_response_to | 2.37601016 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 2.35072098 |
| 21 | MP0005671_abnormal_response_to | 2.30801827 |
| 22 | MP0009046_muscle_twitch | 2.30636503 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.28309739 |
| 24 | MP0005645_abnormal_hypothalamus_physiol | 2.28101192 |
| 25 | MP0001790_abnormal_immune_system | 2.26078653 |
| 26 | MP0005387_immune_system_phenotype | 2.26078653 |
| 27 | MP0001984_abnormal_olfaction | 2.20156444 |
| 28 | MP0000566_synostosis | 2.19068857 |
| 29 | MP0005423_abnormal_somatic_nervous | 2.15092645 |
| 30 | MP0009764_decreased_sensitivity_to | 2.14262512 |
| 31 | MP0000604_amyloidosis | 2.08992259 |
| 32 | MP0003075_altered_response_to | 2.07590816 |
| 33 | MP0000343_altered_response_to | 2.04764179 |
| 34 | MP0001533_abnormal_skeleton_physiology | 2.03591539 |
| 35 | MP0001502_abnormal_circadian_rhythm | 1.98833683 |
| 36 | MP0006292_abnormal_olfactory_placode | 1.98219857 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.94743180 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.94361291 |
| 39 | MP0000685_abnormal_immune_system | 1.93712711 |
| 40 | MP0002452_abnormal_antigen_presenting | 1.93214870 |
| 41 | MP0002723_abnormal_immune_serum | 1.92207964 |
| 42 | MP0005451_abnormal_body_composition | 1.82358813 |
| 43 | MP0002063_abnormal_learning/memory/cond | 1.81976368 |
| 44 | MP0009278_abnormal_bone_marrow | 1.81473212 |
| 45 | MP0002064_seizures | 1.76351735 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.75278351 |
| 47 | MP0005670_abnormal_white_adipose | 1.74973811 |
| 48 | MP0002254_reproductive_system_inflammat | 1.74398576 |
| 49 | MP0001800_abnormal_humoral_immune | 1.73198359 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.69812228 |
| 51 | MP0001819_abnormal_immune_cell | 1.68577740 |
| 52 | MP0002572_abnormal_emotion/affect_behav | 1.68017531 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.67503482 |
| 54 | MP0000778_abnormal_nervous_system | 1.67348872 |
| 55 | MP0002735_abnormal_chemical_nociception | 1.66406070 |
| 56 | MP0009745_abnormal_behavioral_response | 1.65489007 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.64026327 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.56270960 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.53777936 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.53656362 |
| 61 | MP0008469_abnormal_protein_level | 1.51154598 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.50692649 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.49120271 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.48840719 |
| 65 | MP0003880_abnormal_central_pattern | 1.48367962 |
| 66 | MP0006054_spinal_hemorrhage | 1.47838071 |
| 67 | MP0001968_abnormal_touch/_nociception | 1.47793182 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.46355523 |
| 69 | * MP0002067_abnormal_sensory_capabilities | 1.44140426 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.43460911 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.42818333 |
| 72 | MP0002405_respiratory_system_inflammati | 1.42158595 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 1.41833108 |
| 74 | MP0002184_abnormal_innervation | 1.41216003 |
| 75 | MP0001501_abnormal_sleep_pattern | 1.40474538 |
| 76 | MP0003329_amyloid_beta_deposits | 1.38718012 |
| 77 | MP0002734_abnormal_mechanical_nocicepti | 1.37107248 |
| 78 | MP0005365_abnormal_bile_salt | 1.36534422 |
| 79 | MP0003879_abnormal_hair_cell | 1.36524667 |
| 80 | MP0006276_abnormal_autonomic_nervous | 1.36250376 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 1.35636462 |
| 82 | MP0001545_abnormal_hematopoietic_system | 1.35636462 |
| 83 | MP0004510_myositis | 1.34846583 |
| 84 | MP0003045_fibrosis | 1.34536806 |
| 85 | MP0008569_lethality_at_weaning | 1.34444010 |
| 86 | MP0004742_abnormal_vestibular_system | 1.31135855 |
| 87 | MP0003868_abnormal_feces_composition | 1.30744021 |
| 88 | MP0002736_abnormal_nociception_after | 1.29947971 |
| 89 | MP0001440_abnormal_grooming_behavior | 1.29668048 |
| 90 | MP0008260_abnormal_autophagy | 1.29580015 |
| 91 | MP0002272_abnormal_nervous_system | 1.28876494 |
| 92 | MP0004270_analgesia | 1.27972619 |
| 93 | MP0004947_skin_inflammation | 1.26764816 |
| 94 | MP0002139_abnormal_hepatobiliary_system | 1.26619939 |
| 95 | MP0002837_dystrophic_cardiac_calcinosis | 1.20481484 |
| 96 | MP0000579_abnormal_nail_morphology | 1.19208611 |
| 97 | MP0000955_abnormal_spinal_cord | 1.14940572 |
| 98 | MP0003122_maternal_imprinting | 1.14713817 |
| 99 | MP0010386_abnormal_urinary_bladder | 1.14185487 |
| 100 | MP0000716_abnormal_immune_system | 1.13895020 |
| 101 | MP0003121_genomic_imprinting | 1.12028501 |
| 102 | MP0001188_hyperpigmentation | 1.11879528 |
| 103 | MP0005166_decreased_susceptibility_to | 1.11639026 |
| 104 | MP0002882_abnormal_neuron_morphology | 1.11467816 |
| 105 | MP0002332_abnormal_exercise_endurance | 1.10996061 |
| 106 | MP0002138_abnormal_hepatobiliary_system | 1.08854359 |
| 107 | MP0005257_abnormal_intraocular_pressure | 1.06832976 |
| 108 | MP0003252_abnormal_bile_duct | 1.06171042 |
| 109 | MP0010155_abnormal_intestine_physiology | 1.05306208 |
| 110 | MP0001853_heart_inflammation | 1.05161663 |
| 111 | MP0004381_abnormal_hair_follicle | 1.04950956 |
| 112 | MP0000371_diluted_coat_color | 1.04811443 |
| 113 | MP0004858_abnormal_nervous_system | 1.03644729 |
| 114 | MP0003195_calcinosis | 1.02176903 |
| 115 | MP0002928_abnormal_bile_duct | 1.00609644 |
| 116 | MP0005390_skeleton_phenotype | 0.99745111 |
| 117 | MP0004924_abnormal_behavior | 0.99163727 |
| 118 | MP0005386_behavior/neurological_phenoty | 0.99163727 |
| 119 | MP0000858_altered_metastatic_potential | 0.98932929 |
| 120 | MP0008995_early_reproductive_senescence | 0.96912795 |
| 121 | MP0002733_abnormal_thermal_nociception | 0.96371368 |
| 122 | MP0001542_abnormal_bone_strength | 0.95309982 |
| 123 | MP0003828_pulmonary_edema | 0.94985237 |
| 124 | MP0005174_abnormal_tail_pigmentation | 0.94948026 |
| 125 | MP0003279_aneurysm | 0.93443750 |
| 126 | MP0000383_abnormal_hair_follicle | 0.93365254 |
| 127 | MP0003448_altered_tumor_morphology | 0.93099928 |
| 128 | MP0000920_abnormal_myelination | 0.90507560 |
| 129 | MP0002229_neurodegeneration | 0.90300431 |
| 130 | MP0003646_muscle_fatigue | 0.90035451 |
| 131 | MP0003186_abnormal_redox_activity | 0.89614476 |
| 132 | MP0003091_abnormal_cell_migration | 0.89137292 |
| 133 | MP0002429_abnormal_blood_cell | 0.87458424 |
| 134 | MP0008004_abnormal_stomach_pH | 0.87240172 |
| 135 | MP0001970_abnormal_pain_threshold | 0.86839354 |
| 136 | MP0002398_abnormal_bone_marrow | 0.86250348 |
| 137 | MP0005075_abnormal_melanosome_morpholog | 0.86069681 |
| 138 | MP0000689_abnormal_spleen_morphology | 0.85256678 |
| 139 | MP0001529_abnormal_vocalization | 0.84068790 |
| 140 | MP0005164_abnormal_response_to | 0.83965984 |
| 141 | * MP0002066_abnormal_motor_capabilities/c | 0.83495705 |
| 142 | MP0000462_abnormal_digestive_system | 0.82395749 |
| 143 | MP0004142_abnormal_muscle_tone | 0.82321053 |
| 144 | * MP0002752_abnormal_somatic_nervous | 0.82099769 |
| 145 | MP0004885_abnormal_endolymph | 0.81982742 |
| 146 | MP0001324_abnormal_eye_pigmentation | 0.81773532 |
| 147 | MP0002234_abnormal_pharynx_morphology | 0.80578650 |
| 148 | * MP0002152_abnormal_brain_morphology | 0.80512334 |
| 149 | MP0004811_abnormal_neuron_physiology | 0.80276595 |
| 150 | MP0002069_abnormal_eating/drinking_beha | 0.79256917 |
| 151 | MP0009763_increased_sensitivity_to | 0.78782803 |
| 152 | MP0001299_abnormal_eye_distance/ | 0.78446868 |
| 153 | MP0003699_abnormal_female_reproductive | 0.77183978 |
| 154 | MP0002933_joint_inflammation | 0.75105223 |
| 155 | MP0005319_abnormal_enzyme/_coenzyme | 0.73926098 |
| 156 | MP0005394_taste/olfaction_phenotype | 0.73694680 |
| 157 | MP0005499_abnormal_olfactory_system | 0.73694680 |
| 158 | MP0001963_abnormal_hearing_physiology | 0.72774070 |
| 159 | MP0003795_abnormal_bone_structure | 0.72019129 |
| 160 | MP0005197_abnormal_uvea_morphology | 0.71333645 |
| 161 | MP0000026_abnormal_inner_ear | 0.71206995 |
| 162 | MP0002722_abnormal_immune_system | 0.70443777 |
| 163 | MP0008874_decreased_physiological_sensi | 0.70271555 |
| 164 | MP0001663_abnormal_digestive_system | 0.69556321 |
| 165 | MP0002168_other_aberrant_phenotype | 0.69355218 |
| 166 | MP0005595_abnormal_vascular_smooth | 0.68935234 |
| 167 | MP0005165_increased_susceptibility_to | 0.68480928 |
| 168 | MP0004145_abnormal_muscle_electrophysio | 0.67059701 |
| 169 | MP0003690_abnormal_glial_cell | 0.66977409 |
| 170 | MP0002090_abnormal_vision | 0.66621135 |
| 171 | MP0005310_abnormal_salivary_gland | 0.66573698 |
| 172 | MP0000249_abnormal_blood_vessel | 0.66507022 |
| 173 | MP0003453_abnormal_keratinocyte_physiol | 0.65594271 |
| 174 | MP0002089_abnormal_postnatal_growth/wei | 0.65292506 |
| 175 | MP0004883_abnormal_blood_vessel | 0.65190742 |
| 176 | * MP0003632_abnormal_nervous_system | 0.65134969 |
| 177 | MP0005360_urolithiasis | 0.64614457 |
| 178 | MP0005535_abnormal_body_temperature | 0.63888298 |
| 179 | MP0001764_abnormal_homeostasis | 0.60102556 |
| 180 | MP0001986_abnormal_taste_sensitivity | 0.59997068 |
| 181 | MP0009765_abnormal_xenobiotic_induced | 0.59300518 |
| 182 | MP0002693_abnormal_pancreas_physiology | 0.58872762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Abnormality of glycolipid metabolism (HP:0010969) | 6.83037941 |
| 2 | * Abnormality of liposaccharide metabolism (HP:0010968) | 6.83037941 |
| 3 | * Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.83037941 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.37397470 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.22673364 |
| 6 | Dysostosis multiplex (HP:0000943) | 4.86255786 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.74689353 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.68327279 |
| 9 | Febrile seizures (HP:0002373) | 4.67230967 |
| 10 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.39087591 |
| 11 | Loss of speech (HP:0002371) | 4.30571469 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.09632928 |
| 13 | Stomatitis (HP:0010280) | 3.96819000 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.94343535 |
| 15 | Myositis (HP:0100614) | 3.94231576 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.93662729 |
| 17 | Orchitis (HP:0100796) | 3.86203418 |
| 18 | * Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.82167414 |
| 19 | Mucopolysacchariduria (HP:0008155) | 3.82167414 |
| 20 | * Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.82167414 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.82167414 |
| 22 | * Abnormality of polysaccharide metabolism (HP:0011012) | 3.82167414 |
| 23 | Chromsome breakage (HP:0040012) | 3.62044024 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.61544563 |
| 25 | Optic neuritis (HP:0100653) | 3.61544563 |
| 26 | Focal motor seizures (HP:0011153) | 3.46925041 |
| 27 | Disinhibition (HP:0000734) | 3.36682773 |
| 28 | Prostate neoplasm (HP:0100787) | 3.34010708 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.26190642 |
| 30 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.08143301 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.04657088 |
| 32 | Focal seizures (HP:0007359) | 3.04339382 |
| 33 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.03343431 |
| 34 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.96102351 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.93380961 |
| 36 | Progressive neurologic deterioration (HP:0002344) | 2.85991819 |
| 37 | Congenital stationary night blindness (HP:0007642) | 2.83877535 |
| 38 | Hematochezia (HP:0002573) | 2.81691865 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.78628707 |
| 40 | Abnormality of the fingertips (HP:0001211) | 2.78013428 |
| 41 | Increased serum ferritin (HP:0003281) | 2.77807422 |
| 42 | Progressive cerebellar ataxia (HP:0002073) | 2.76894522 |
| 43 | Amyloidosis (HP:0011034) | 2.74572916 |
| 44 | Anosmia (HP:0000458) | 2.73035325 |
| 45 | Petechiae (HP:0000967) | 2.70883209 |
| 46 | Nuclear cataract (HP:0100018) | 2.68893882 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67944241 |
| 48 | Obstructive lung disease (HP:0006536) | 2.67944241 |
| 49 | Genetic anticipation (HP:0003743) | 2.66978960 |
| 50 | Neurofibrillary tangles (HP:0002185) | 2.66429396 |
| 51 | Axonal loss (HP:0003447) | 2.57912726 |
| 52 | Albinism (HP:0001022) | 2.56403967 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.53846688 |
| 54 | Recurrent skin infections (HP:0001581) | 2.49732532 |
| 55 | Purpura (HP:0000979) | 2.49607017 |
| 56 | Epileptic encephalopathy (HP:0200134) | 2.49045195 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.47943400 |
| 58 | Hemoptysis (HP:0002105) | 2.46749787 |
| 59 | Prolonged neonatal jaundice (HP:0006579) | 2.46641421 |
| 60 | Diminished motivation (HP:0000745) | 2.46160836 |
| 61 | Keratoconjunctivitis sicca (HP:0001097) | 2.45234941 |
| 62 | Keratoconjunctivitis (HP:0001096) | 2.41735001 |
| 63 | Abnormality of iron homeostasis (HP:0011031) | 2.41063715 |
| 64 | Hepatosplenomegaly (HP:0001433) | 2.37841452 |
| 65 | Apathy (HP:0000741) | 2.37752908 |
| 66 | J-shaped sella turcica (HP:0002680) | 2.37543781 |
| 67 | Heterotopia (HP:0002282) | 2.32894685 |
| 68 | Drooling (HP:0002307) | 2.19959277 |
| 69 | Excessive salivation (HP:0003781) | 2.19959277 |
| 70 | Abnormality of lateral ventricle (HP:0030047) | 2.19795701 |
| 71 | Supranuclear gaze palsy (HP:0000605) | 2.19583782 |
| 72 | Episodic fever (HP:0001954) | 2.18571853 |
| 73 | Gaze-evoked nystagmus (HP:0000640) | 2.17902725 |
| 74 | Elfin facies (HP:0004428) | 2.17403919 |
| 75 | Increased CSF protein (HP:0002922) | 2.15013503 |
| 76 | Spontaneous hematomas (HP:0007420) | 2.14268514 |
| 77 | Urticaria (HP:0001025) | 2.13538955 |
| 78 | Lower limb amyotrophy (HP:0007210) | 2.13353078 |
| 79 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.13166033 |
| 80 | Mask-like facies (HP:0000298) | 2.12997529 |
| 81 | Distal lower limb amyotrophy (HP:0008944) | 2.11180612 |
| 82 | Increased IgM level (HP:0003496) | 2.10029320 |
| 83 | Vasculitis (HP:0002633) | 2.09382453 |
| 84 | Lip pit (HP:0100267) | 2.09020734 |
| 85 | Action tremor (HP:0002345) | 2.08723970 |
| 86 | Generalized hypopigmentation of hair (HP:0011358) | 2.08659086 |
| 87 | Pustule (HP:0200039) | 2.08578794 |
| 88 | Postural instability (HP:0002172) | 2.08505647 |
| 89 | Upper motor neuron abnormality (HP:0002127) | 2.07361323 |
| 90 | Mesangial abnormality (HP:0001966) | 2.06749422 |
| 91 | Recurrent cutaneous fungal infections (HP:0011370) | 2.03987502 |
| 92 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.03987502 |
| 93 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.03239783 |
| 94 | Turricephaly (HP:0000262) | 2.03200468 |
| 95 | Meningitis (HP:0001287) | 2.03191939 |
| 96 | Glomerulonephritis (HP:0000099) | 2.03074688 |
| 97 | Polyphagia (HP:0002591) | 2.03027386 |
| 98 | Dementia (HP:0000726) | 2.02603757 |
| 99 | Asymmetric septal hypertrophy (HP:0001670) | 2.02469192 |
| 100 | Encephalitis (HP:0002383) | 1.99379998 |
| 101 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.98398955 |
| 102 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.96611291 |
| 103 | Cardiomegaly (HP:0001640) | 1.96470429 |
| 104 | Generalized tonic-clonic seizures (HP:0002069) | 1.94610292 |
| 105 | Ectopic kidney (HP:0000086) | 1.94411374 |
| 106 | Hip dysplasia (HP:0001385) | 1.94267186 |
| 107 | Global brain atrophy (HP:0002283) | 1.93925481 |
| 108 | Narrow nasal bridge (HP:0000446) | 1.93886557 |
| 109 | Severe visual impairment (HP:0001141) | 1.91623363 |
| 110 | Polyneuropathy (HP:0001271) | 1.91102744 |
| 111 | Decreased central vision (HP:0007663) | 1.90973528 |
| 112 | Abnormality of the pericardium (HP:0001697) | 1.90626601 |
| 113 | Inappropriate behavior (HP:0000719) | 1.89638882 |
| 114 | Conjugated hyperbilirubinemia (HP:0002908) | 1.89044775 |
| 115 | Tetany (HP:0001281) | 1.88403982 |
| 116 | Hypoplasia of the fovea (HP:0007750) | 1.86394026 |
| 117 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.86394026 |
| 118 | Anal stenosis (HP:0002025) | 1.86251347 |
| 119 | Papillary thyroid carcinoma (HP:0002895) | 1.86082103 |
| 120 | Urethral obstruction (HP:0000796) | 1.85852378 |
| 121 | Cerebral inclusion bodies (HP:0100314) | 1.85673821 |
| 122 | Abnormality of macular pigmentation (HP:0008002) | 1.85512204 |
| 123 | Anorexia (HP:0002039) | 1.84956886 |
| 124 | Vertebral compression fractures (HP:0002953) | 1.84168055 |
| 125 | Hemiplegia (HP:0002301) | 1.83955760 |
| 126 | Renovascular hypertension (HP:0100817) | 1.83147364 |
| 127 | Oligodactyly (hands) (HP:0001180) | 1.82588931 |
| 128 | Myokymia (HP:0002411) | 1.82552319 |
| 129 | Narrow palate (HP:0000189) | 1.81934267 |
| 130 | Growth hormone deficiency (HP:0000824) | 1.79430289 |
| 131 | Acne (HP:0001061) | 1.78769875 |
| 132 | Gastrointestinal infarctions (HP:0005244) | 1.77409845 |
| 133 | Abnormality of the periventricular white matter (HP:0002518) | 1.76970082 |
| 134 | Joint stiffness (HP:0001387) | 1.76963072 |
| 135 | Onion bulb formation (HP:0003383) | 1.76872252 |
| 136 | Oligodontia (HP:0000677) | 1.76838474 |
| 137 | Fair hair (HP:0002286) | 1.76790309 |
| 138 | Generalized hypopigmentation (HP:0007513) | 1.76166701 |
| 139 | Myocardial infarction (HP:0001658) | 1.75976186 |
| 140 | Chronic hepatic failure (HP:0100626) | 1.75524212 |
| 141 | Abnormality of the pleura (HP:0002103) | 1.75266911 |
| 142 | Protruding tongue (HP:0010808) | 1.74693542 |
| 143 | Pathologic fracture (HP:0002756) | 1.74482618 |
| 144 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.73993637 |
| 145 | Atonic seizures (HP:0010819) | 1.73543634 |
| 146 | Iris hypopigmentation (HP:0007730) | 1.72720622 |
| 147 | Status epilepticus (HP:0002133) | 1.70839927 |
| 148 | Tented upper lip vermilion (HP:0010804) | 1.70802430 |
| 149 | Dysmetria (HP:0001310) | 1.70586019 |
| 150 | Slow saccadic eye movements (HP:0000514) | 1.70354712 |
| 151 | Upper limb muscle weakness (HP:0003484) | 1.70125183 |
| 152 | Leukocytosis (HP:0001974) | 1.68157436 |
| 153 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.68037590 |
| 154 | Septo-optic dysplasia (HP:0100842) | 1.67962614 |
| 155 | Neuronal loss in central nervous system (HP:0002529) | 1.67804782 |
| 156 | Sleep apnea (HP:0010535) | 1.67324665 |
| 157 | Ankle clonus (HP:0011448) | 1.67183422 |
| 158 | Chest pain (HP:0100749) | 1.66513340 |
| 159 | Mutism (HP:0002300) | 1.66286035 |
| 160 | Abnormality of the renal collecting system (HP:0004742) | 1.65599915 |
| 161 | Impaired social interactions (HP:0000735) | 1.65588585 |
| 162 | Abnormal social behavior (HP:0012433) | 1.65588585 |
| 163 | Agitation (HP:0000713) | 1.65355917 |
| 164 | Vertigo (HP:0002321) | 1.64734188 |
| 165 | Dyschromatopsia (HP:0007641) | 1.64555004 |
| 166 | Epistaxis (HP:0000421) | 1.64480963 |
| 167 | Abnormality of the carotid arteries (HP:0005344) | 1.64344307 |
| 168 | Macroorchidism (HP:0000053) | 1.62877711 |
| 169 | Abnormality of the fovea (HP:0000493) | 1.61721930 |
| 170 | Abnormal eating behavior (HP:0100738) | 1.61100473 |
| 171 | Retinal atrophy (HP:0001105) | 1.61099918 |
| 172 | Ocular albinism (HP:0001107) | 1.60582171 |
| 173 | Abolished electroretinogram (ERG) (HP:0000550) | 1.59072920 |
| 174 | Abnormality of salivation (HP:0100755) | 1.58470045 |
| 175 | Failure to thrive in infancy (HP:0001531) | 1.57954260 |
| 176 | Spinal canal stenosis (HP:0003416) | 1.57839804 |
| 177 | Long eyelashes (HP:0000527) | 1.56813389 |
| 178 | Small hand (HP:0200055) | 1.56337487 |
| 179 | Arterial tortuosity (HP:0005116) | 1.55756544 |
| 180 | Long toe (HP:0010511) | 1.55483684 |
| 181 | Trigonocephaly (HP:0000243) | 1.55220027 |
| 182 | Broad-based gait (HP:0002136) | 1.55089092 |
| 183 | Confusion (HP:0001289) | 1.54661915 |
| 184 | Poor eye contact (HP:0000817) | 1.54603952 |
| 185 | Gingivitis (HP:0000230) | 1.54512343 |
| 186 | Acute lymphatic leukemia (HP:0006721) | 1.54274532 |
| 187 | Dysdiadochokinesis (HP:0002075) | 1.53636523 |
| 188 | Abnormality of DNA repair (HP:0003254) | 1.52129393 |
| 189 | Exotropia (HP:0000577) | 1.52068012 |
| 190 | Depressed nasal tip (HP:0000437) | 1.50842929 |
| 191 | Abnormal hair whorl (HP:0010721) | 1.50665397 |
| 192 | Central scotoma (HP:0000603) | 1.50147129 |
| 193 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.49537012 |
| 194 | Duplicated collecting system (HP:0000081) | 1.48505012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 3.47043106 |
| 2 | MAP3K11 | 3.14505357 |
| 3 | MAP3K13 | 2.98330929 |
| 4 | SIK2 | 2.83481247 |
| 5 | CDK12 | 2.77537269 |
| 6 | CAMK1D | 2.76701206 |
| 7 | MAP3K9 | 2.73967352 |
| 8 | LATS1 | 2.59736910 |
| 9 | MAP4K1 | 2.57892513 |
| 10 | CAMK1G | 2.53972654 |
| 11 | PRPF4B | 2.52383407 |
| 12 | BLK | 2.47323480 |
| 13 | TAOK3 | 2.46966295 |
| 14 | MAP2K3 | 2.37396142 |
| 15 | TBK1 | 2.26767205 |
| 16 | NTRK3 | 2.18871464 |
| 17 | MAP3K3 | 2.17771437 |
| 18 | TESK2 | 2.13952918 |
| 19 | TGFBR2 | 2.07210624 |
| 20 | GRK7 | 2.07011203 |
| 21 | ADRBK2 | 2.01395375 |
| 22 | BRD4 | 1.99758232 |
| 23 | STK38 | 1.97207773 |
| 24 | TXK | 1.83862504 |
| 25 | IKBKB | 1.77136055 |
| 26 | NME2 | 1.75209510 |
| 27 | INSRR | 1.74768121 |
| 28 | MAP3K4 | 1.63208445 |
| 29 | PAK6 | 1.61981107 |
| 30 | EPHA4 | 1.60489489 |
| 31 | MATK | 1.59783095 |
| 32 | CSK | 1.59143948 |
| 33 | FGR | 1.58373202 |
| 34 | MAP3K6 | 1.53847957 |
| 35 | SGK2 | 1.49230770 |
| 36 | BCKDK | 1.45911177 |
| 37 | ZAP70 | 1.42651975 |
| 38 | MAP2K7 | 1.41825303 |
| 39 | KSR1 | 1.40300615 |
| 40 | MARK2 | 1.38479674 |
| 41 | LATS2 | 1.37702580 |
| 42 | TNIK | 1.32951985 |
| 43 | ERBB4 | 1.32904139 |
| 44 | MAP2K6 | 1.29696691 |
| 45 | SGK494 | 1.27996283 |
| 46 | SGK223 | 1.27996283 |
| 47 | TAOK2 | 1.27913528 |
| 48 | ABL2 | 1.26922908 |
| 49 | NTRK2 | 1.26682084 |
| 50 | RIPK4 | 1.25856821 |
| 51 | SIK1 | 1.25552587 |
| 52 | SGK3 | 1.22712729 |
| 53 | DAPK2 | 1.21991635 |
| 54 | TESK1 | 1.21930219 |
| 55 | PIM2 | 1.19999040 |
| 56 | RIPK1 | 1.18464895 |
| 57 | ACVR1B | 1.14718603 |
| 58 | GRK6 | 1.12680216 |
| 59 | FRK | 1.09674088 |
| 60 | SYK | 1.07961987 |
| 61 | IRAK3 | 1.07709489 |
| 62 | STK38L | 1.02755884 |
| 63 | KDR | 1.02138750 |
| 64 | CSF1R | 1.01556219 |
| 65 | LYN | 0.99905843 |
| 66 | MAP2K4 | 0.99860703 |
| 67 | CAMKK2 | 0.97933283 |
| 68 | DDR2 | 0.96867057 |
| 69 | TAOK1 | 0.96444722 |
| 70 | MAPK13 | 0.95773821 |
| 71 | ERN1 | 0.90842878 |
| 72 | JAK1 | 0.89011947 |
| 73 | IRAK2 | 0.87442084 |
| 74 | EPHB1 | 0.85329775 |
| 75 | CAMK4 | 0.84181730 |
| 76 | PTK2B | 0.82620091 |
| 77 | MUSK | 0.82241822 |
| 78 | SGK1 | 0.82196036 |
| 79 | PRKAA2 | 0.80690309 |
| 80 | ICK | 0.78978294 |
| 81 | NEK6 | 0.77075643 |
| 82 | CDK3 | 0.76730256 |
| 83 | PINK1 | 0.76090119 |
| 84 | LIMK1 | 0.75910551 |
| 85 | GRK1 | 0.75556930 |
| 86 | MINK1 | 0.75548982 |
| 87 | MARK1 | 0.75037479 |
| 88 | MAP3K7 | 0.74181958 |
| 89 | IRAK4 | 0.73184200 |
| 90 | LCK | 0.72904508 |
| 91 | PRKCH | 0.72598185 |
| 92 | MAP4K2 | 0.71613824 |
| 93 | PRKG2 | 0.71489228 |
| 94 | MAPKAPK3 | 0.70995411 |
| 95 | CDC42BPA | 0.69761865 |
| 96 | CAMK1 | 0.69759696 |
| 97 | PRKD2 | 0.69006529 |
| 98 | KSR2 | 0.67382587 |
| 99 | PDPK1 | 0.66686818 |
| 100 | TNK2 | 0.66281468 |
| 101 | MAPK7 | 0.65571231 |
| 102 | PRKAA1 | 0.65294797 |
| 103 | JAK2 | 0.63419972 |
| 104 | TYRO3 | 0.63328906 |
| 105 | HIPK2 | 0.60542076 |
| 106 | CDK5 | 0.59896992 |
| 107 | HCK | 0.59852745 |
| 108 | ADRBK1 | 0.59577318 |
| 109 | BTK | 0.58540215 |
| 110 | IKBKE | 0.57604563 |
| 111 | FES | 0.57093030 |
| 112 | EPHB2 | 0.56606984 |
| 113 | * MAPK10 | 0.55000505 |
| 114 | PDK1 | 0.54356536 |
| 115 | CAMKK1 | 0.54319384 |
| 116 | MAP3K5 | 0.54282951 |
| 117 | MOS | 0.53496447 |
| 118 | RPS6KA2 | 0.52637622 |
| 119 | RPS6KA6 | 0.51843057 |
| 120 | IRAK1 | 0.51823198 |
| 121 | CDK9 | 0.51677659 |
| 122 | DMPK | 0.51073743 |
| 123 | DYRK1A | 0.48531501 |
| 124 | RPS6KC1 | 0.47093044 |
| 125 | RPS6KL1 | 0.47093044 |
| 126 | ERBB2 | 0.46924524 |
| 127 | CSNK1G3 | 0.44871941 |
| 128 | PTK2 | 0.43620972 |
| 129 | WNK1 | 0.42884598 |
| 130 | ZAK | 0.42741678 |
| 131 | JAK3 | 0.41699017 |
| 132 | KIT | 0.41050698 |
| 133 | MAPK12 | 0.40599907 |
| 134 | CSNK1A1L | 0.39595514 |
| 135 | PRKCZ | 0.39512916 |
| 136 | MAP3K1 | 0.39431360 |
| 137 | CHUK | 0.38479181 |
| 138 | CAMK2A | 0.38034447 |
| 139 | PRKD3 | 0.37820512 |
| 140 | STK11 | 0.37508060 |
| 141 | TYK2 | 0.37390550 |
| 142 | ARAF | 0.37322946 |
| 143 | TGFBR1 | 0.37202083 |
| 144 | MAPK8 | 0.36384978 |
| 145 | GRK5 | 0.36178189 |
| 146 | ITK | 0.35648621 |
| 147 | STK10 | 0.35051759 |
| 148 | MTOR | 0.35050768 |
| 149 | FGFR4 | 0.34963488 |
| 150 | NUAK1 | 0.34866577 |
| 151 | ABL1 | 0.34412954 |
| 152 | BMPR2 | 0.33823478 |
| 153 | PRKCQ | 0.33804177 |
| 154 | MARK3 | 0.33536926 |
| 155 | GSK3B | 0.33371494 |
| 156 | MAP3K14 | 0.32806891 |
| 157 | PDGFRB | 0.32056882 |
| 158 | PRKD1 | 0.32048986 |
| 159 | AKT2 | 0.31750232 |
| 160 | RPS6KA3 | 0.31129968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.75692759 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.54053734 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.23609590 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.14871743 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.08026363 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.03751828 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.02332872 |
| 8 | Asthma_Homo sapiens_hsa05310 | 1.99537053 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 1.89689173 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82521148 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.80579421 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78261419 |
| 13 | Phagosome_Homo sapiens_hsa04145 | 1.78155170 |
| 14 | Lysine degradation_Homo sapiens_hsa00310 | 1.77749770 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.76004975 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.75057505 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69956461 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.68300338 |
| 19 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.64509306 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.63648144 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63464358 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60967456 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.56720516 |
| 24 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.55719579 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.49894110 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.49315965 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49224972 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.48925784 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.48788753 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.48526776 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.43808834 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42286734 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.38891609 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38629378 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.37190743 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.36871443 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.33684057 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.28988309 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22722616 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22017721 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20678045 |
| 42 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.19366512 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.17569274 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.13795011 |
| 45 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.12719749 |
| 46 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.12035517 |
| 47 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.11975376 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11719725 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 1.11677739 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10720292 |
| 51 | Cocaine addiction_Homo sapiens_hsa05030 | 1.08068566 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 1.07377215 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.06946366 |
| 54 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.06322311 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05880514 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03901015 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.03888131 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02417147 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02383999 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.02321154 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.00923479 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00578066 |
| 63 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00437573 |
| 64 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.98632882 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97807466 |
| 66 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97543277 |
| 67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97147143 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93331870 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.90350557 |
| 70 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.88976569 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87707324 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86360714 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85404858 |
| 74 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84962158 |
| 75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84720523 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84314269 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83956950 |
| 78 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.83653455 |
| 79 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.82797392 |
| 80 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81319671 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.81122918 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81051816 |
| 83 | Axon guidance_Homo sapiens_hsa04360 | 0.80414707 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80026478 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79816568 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77362231 |
| 87 | Long-term potentiation_Homo sapiens_hsa04720 | 0.77073160 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75715441 |
| 89 | * Lysosome_Homo sapiens_hsa04142 | 0.75097903 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.74724961 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74406495 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74260636 |
| 93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.74084202 |
| 94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73924374 |
| 95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73232986 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.71659519 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.70940988 |
| 98 | Measles_Homo sapiens_hsa05162 | 0.70674092 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70173695 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70002734 |
| 101 | Long-term depression_Homo sapiens_hsa04730 | 0.68909862 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68869838 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68860140 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67610281 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67448029 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.67105184 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65369640 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.64131689 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63762600 |
| 110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.63731951 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63216719 |
| 112 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62990488 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62857069 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61998980 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61619040 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61597232 |
| 117 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61324736 |
| 118 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61125685 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60917883 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.60901908 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60601470 |
| 122 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59338885 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59203617 |
| 124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57561715 |
| 125 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56929147 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.54036968 |
| 127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53414566 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52742806 |
| 129 | Melanogenesis_Homo sapiens_hsa04916 | 0.51475194 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51303636 |
| 131 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50901741 |
| 132 | Hepatitis B_Homo sapiens_hsa05161 | 0.50773915 |
| 133 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50694154 |
| 134 | Renin secretion_Homo sapiens_hsa04924 | 0.50520959 |
| 135 | Tuberculosis_Homo sapiens_hsa05152 | 0.50277730 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50147064 |
| 137 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49876696 |
| 138 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49733815 |
| 139 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49605896 |
| 140 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47821373 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47154461 |
| 142 | Amoebiasis_Homo sapiens_hsa05146 | 0.47126623 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46218268 |
| 144 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46188345 |
| 145 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44098619 |
| 146 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43729141 |
| 147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43615105 |
| 148 | Gap junction_Homo sapiens_hsa04540 | 0.43439797 |
| 149 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42592420 |
| 150 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42017220 |
| 151 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41766747 |
| 152 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41177856 |
| 153 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40611231 |
| 154 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40598047 |
| 155 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40299533 |
| 156 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39632178 |
| 157 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39304495 |
| 158 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38779633 |
| 159 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35060273 |
| 160 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.34983277 |
| 161 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31034604 |
| 162 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30911531 |
| 163 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.30842980 |
| 164 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30423433 |
| 165 | Platelet activation_Homo sapiens_hsa04611 | 0.25755993 |
| 166 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.25165867 |
| 167 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.23680004 |
| 168 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.18771246 |

